Bone sarcoma mortality statistics

Deaths

Deaths from bone sarcoma, 2014, UK

 

Proportion of all deaths

Percentage bone sarcoma is of total cancer deaths, 2014, UK

 

Age

Peak rate of bone sarcoma deaths, 2012-2014, UK

 

Trend over time

Bone sarcoma mortality rates have decreased by 62% since the early 1970s, UK

 

Bone sarcoma accounts for less than 1% of cancer deaths in the UK for males and females combined (2014) and is not among the 20 most common causes of cancer death.[1-3] In males, it is the 19th most common cause of cancer deaths in the UK (less than 1% of all male cancer deaths), whilst in females it is not among the 20 most common causes of cancer death in the UK (less than 1% of all female cancer deaths).[1-3]

In 2014, there were 355 bone sarcoma deaths in the UK: 195 (55%) in males and 160 (45%) in females, giving a male:female ratio of around 12:10.[1-3] The crude mortality rate Open a glossary item shows that there is less than 1 bone sarcoma death for every 100,000 males in the UK, and less than 1 for every 100,000 females.

The European age-standardised mortality rates Open a glossary item (AS rates) do not differ significantly between the constituent countries of the UK for either sex.[1-3]

Bone Sarcoma (C40-C41), Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK, 2014

England Wales Scotland Northern Ireland UK
Male Deaths 161 15 15 4 195
Crude Rate 0.6 1.0 0.6 0.4 0.6
AS Rate 0.7 1.0 0.6 0.5 0.7
AS Rate - 95% LCL 0.6 0.5 0.3 0.0 0.6
AS Rate - 95% UCL 0.8 1.6 1.0 0.9 0.8
Female Deaths 118 15 17 10 160
Crude Rate 0.4 1.0 0.6 1.1 0.5
AS Rate 0.4 0.9 0.6 1.1 0.5
AS Rate - 95% LCL 0.4 0.5 0.3 0.4 0.4
AS Rate - 95% UCL 0.5 1.4 0.9 1.8 0.6
Persons Deaths 279 30 32 14 355
Crude Rate 0.5 1.0 0.6 0.8 0.5
AS Rate 0.5 1.0 0.6 0.8 0.6
AS Rate - 95% LCL 0.5 0.6 0.4 0.4 0.5
AS Rate - 95% UCL 0.6 1.3 0.8 1.2 0.6

95% LCL and 95% UCL are the 95% lower and upper confidence limits Open a glossary item around the AS rate Open a glossary item

References

  1. Data were provided by the Office for National Statistics on request, November 2015. Similar data can be found here: https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/bulletins/deathsregistrationsummarytables/previousReleases.
  2. Data were provided by the Information Services Division (ISD) Scotland on request, November 2015. Similar data can be found here: http://www.nrscotland.gov.uk/statistics-and-data/statistics/statistics-by-theme/vital-events/vital-events-reference-tables.
  3. Data were provided by the Northern Ireland Statistics and Research Agency on request, November 2015. Similar data can be found here: http://www.nisra.gov.uk/demography/default.asp2.htm.
Last reviewed:

Bone sarcoma mortality is strongly related to age, with the highest mortality rates being in older males and females (though there is also a small peak in teenagers). In the UK in 2012-2014, on average each year more than half (53%) of deaths were in people aged 60 and over.[1-3]

Age-specific mortality rates rise steadily from birth to around age 15-19, then drop at a similar pace until around age 35-39 and 40-44; rates then increase steadily until around age 70-74 and 75-79, and more rapidly thereafter, with the highest rates in the 90+ age group in both sexes. Mortality rates are significantly higher for males than for females in those aged 55-59 when the male:female ratio of age-specific  rates (to account for the different proportions of males to females in each age group) is around 25:10.[1-3]

Bone Sarcoma (C40-C41), Average Number of Deaths per Year and Age-Specific Mortality Rates per Million, UK, 2012-2014

For most cancer types, mortality by age largely reflects incidence and survival by age, e.g. typically, higher incidence and lower survival in older people results in higher mortality in older people.

References

  1. Data were provided by the Office for National Statistics on request, November 2015. Similar data can be found here: https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/bulletins/deathsregistrationsummarytables/previousReleases.
  2. Data were provided by the Information Services Division (ISD) Scotland on request, November 2015. Similar data can be found here: http://www.nrscotland.gov.uk/statistics-and-data/statistics/statistics-by-theme/vital-events/vital-events-reference-tables.
  3. Data were provided by the Northern Ireland Statistics and Research Agency on request, November 2015.Similar data can be found here: http://www.nisra.gov.uk/demography/default.asp2.htm.
Last reviewed:

Bone sarcoma mortality rates have decreased by 62% in the UK since the early 1970s.[1,3] This includes a similar decrease for males and females and for both sexes there has been a decrease followed by a period of stability during this time.

For males, European age standardised (AS) Open a glossary item mortality rates decreased by 61% between 1971-1973 and 1986-1988 and have remained stable between 1986-1988 and 2012-2014. For females, rates decreased by 60% between 1971-1973 and 1989-1991 and have remained stable between 1989-1991and 2012-2014.

Over the last decade in the UK (between 2003-2005 and 2012-2014), bone sarcoma AS mortality rates have remained stable in the UK, for males and females combined and separately.[1-3]

Bone Sarcoma (C40-C41), European Age-Standardised Mortality Rates per Million, UK, 1971-2014

For most cancer types, mortality trends largely reflect incidence and survival trends, e.g. increased incidence without sufficient survival improvement results in increased mortality.

Bone sarcoma mortality rates have decreased overall for all of the specific broad age groups in the UK since the early 1970s.[1-3] The largest decrease has been in people aged 60-69, with rates falling by 74% between 1971-1973 and 2012-2014.

Bone Sarcoma (C40-C41), European Age-Standardised Mortality Rates, per million, by Age, Persons, UK, 1971-2014

References

  1. Data were provided by the Office for National Statistics on request, November 2015. Similar data can be found here: https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/bulletins/deathsregistrationsummarytables/previousReleases.
  2. Data were provided by the Information Services Division (ISD) Scotland on request, November 2015. Similar data can be found here: http://www.nrscotland.gov.uk/statistics-and-data/statistics/statistics-by-theme/vital-events/vital-events-reference-tables.
  3. Data were provided by the Northern Ireland Statistics and Research Agency on request, November 2015. Similar data can be found here: http://www.nisra.gov.uk/demography/default.asp2.htm.
Last reviewed:

Bone sarcoma mortality rates are projected to fall by 23% in the UK between 2014 and 2035, to 1 death per 100,000 people by 2035.[1] This includes a larger decrease for males than for females.

For males, bone sarcoma European age-standardised (AS) Open a glossary item mortality rates in the UK are projected to fall by 40% between 2014 and 2035, to fewer than 1 death per 100,000 by 2035.[1] For females, rates are projected to fall by 3% between 2014 and 2035, to 1 death per 100,000 by 2035.[1]

Bone sarcoma (C40-C41), Observed and Projected Age-Standardised Mortality Rates, by Sex, UK, 1979-2035

It is projected that 352 deaths from bone sarcoma (155 in males, 197 in females) will occur in the UK in 2035.

References

  1. Smittenaar CR, Petersen KA, Stewart K, Moitt N. Cancer Incidence and Mortality Projections in the UK Until 2035. Brit J Cancer 2016.

About this data

Data is for: UK, 1979-2014 (observed), 2015-2035 (projected), ICD-10 C40-C41

Projections are based on observed incidence and mortality rates and therefore implicitly include changes in cancer risk factors, diagnosis and treatment. It is not possible to assess the statistical significance of changes between 2014 (observed) and 2035 (projected) figures. Confidence intervals are not calculated for the projected figures. Projections are by their nature uncertain because unexpected events in future could change the trend. It is not sensible to calculate a boundary of uncertainty around these already uncertain point estimates. Changes are described as "increase" or "decrease" if there is any difference between the point estimates.

More on projections methodology

Last reviewed:

There is no evidence for an association between bone sarcoma mortality and deprivation for either males or females in England.[1] England-wide data for 2007-2011 show European age-standardised Open a glossary item mortality rates are similar for both males and females living in the most deprived areas compared with the least deprived.[1]

Bone sarcoma (C40-C41), European Age-Standardised Mortality Rates by Deprivation Quintile, England, 2007-2011

The estimated deprivation gradient in bone sarcoma mortality between people living in the most and least deprived areas in England has not changed in the period 2002-2011.[1

Last reviewed:

Cancer Statistics Explained

See information and explanations on terminology used for statistics and reporting of cancer, and the methods used to calculate some of our statistics.

Citation

You are welcome to reuse this Cancer Research UK statistics content for your own work.

Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year]. 

Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK. 

Rate this page:

Currently rated: 1.3 out of 5 based on 3 votes
Thank you!
We've recently made some changes to the site, tell us what you think

Share this page